CD52

Synonyms

Epididymis Secretory Sperm Binding Protein Li 171mP, CD52 Antigen (CAMPATH-1 Antigen), Epididymal Secretory Protein E5, He5, CDW52 Antigen (CAMPATH-1 Antigen), CD52 Antigen, HEL-S-171mP, EDDM5, CD52, CDw52, Cambridge pathology 1 antigen, Human epididymis-specific protein 5, CAMPATH-1 antigen, CD52 Molecule

KO Status

RenMab: Antibody Discovery

RenLite: F0

Drug Information

Launched drug: 1
Drugs in clinical trials: 3
Latest Research Phase: Approved

Drug Name

Code

Phase

Company

Indications

Clinical Trials

Alemtuzumab

LDP-03, GZ-402673

Approved

Genzyme Corp, Bayer Ag

Hematologic Neoplasms, Graft vs Host Disease, Multiple Sclerosis, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

Alemtuzumab biosimilar (Zhangjiang Biotechnology)

Phase 2 Clinical

Shanghai Zhangjiang Biotechnology Co Ltd

Leukemia, Lymphocytic, Chronic, B-Cell

ALLO-647

ALLO-647

Phase 2 Clinical

Allogene Therapeutics Inc

Lymphoma, B-Cell, Carcinoma, Renal Cell, Multiple Myeloma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Recombinant anti-CD52 humanized monoclonal antibody (Lanzhou Institute Of Biological Products/Shanghai Taiyin Biotechnology)

Phase 1 Clinical

Lanzhou Institute Of Biological Products Co Ltd, Shanghai Taiyin Biotechnology Co Ltd

Leukemia, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, Prolymphocytic, T-Cell, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Alemtuzumab biosimilar(BioXpress Therapeutics)

BX-1523

Preclinical

Bioxpress Therapeutics Sa

Leukemia, Lymphocytic, Chronic, B-Cell

Campath-1G

Discontinued

University Of Cambridge

Graft vs Host Disease, Rejection of organ transplantation

Recombinant anti-CD52 humanized monoclonal antibody (Hisun Pharm)

Discontinued

Zhejiang Hisun Pharmaceutical Co Ltd

Leukemia, Lymphocytic, Chronic, B-Cell

GZ-402668

GLD-52, GZ-402668

Discontinued

Genzyme Corp

Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive